[123I]MNI-420

N/A

Report date: 2025/11/24 17:58:20
NME

Base Information

Drug Name[123I]MNI-420
Drug Alias Name[123I]MNI-420
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Iodine > 123I +[5] 
Mechanisms of ActionAlpha-2a adrenergic receptor antagonists
TargetsAlpha-2a adrenergic receptor
Therapy Area/IndicationsParkinson DiseaseHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInst For Neurodegenerative Disorders
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Institute For Neurodegenerative Disorders Inc
Active IndicationsN/A
Inactive IndicationsParkinson DiseaseHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A